Identification and characterization of the DNA binding domain of CpG-binding protein

被引:119
作者
Lee, JH
Voo, KS
Skalnik, DG
机构
[1] Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Sect Pediat Hematol Oncol, Indianapolis, IN 46202 USA
[2] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA
[3] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA
关键词
D O I
10.1074/jbc.M107179200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CpG-binding protein is a transcriptional activator that exhibits a unique DNA binding specificity for unmethylated CpG motifs. CpG-binding protein contains a cysteine-rich CXXC domain that is conserved in DNA methyltransferase 1, methyl binding domain protein 1, and human trithorax. In vitro DNA binding assays reveal that CpG-binding protein contains a single DNA binding domain comprised of the CXXC domain and a short carboxyl extension. Specific mutation to alanine of individual conserved cysteine residues within the CXXC domain abolishes DNA binding activity. Denaturation/renaturation experiments in the presence of various metal cations demonstrate that the CXXC domain requires zinc for efficient DNA binding activity. Ligand selection of high affinity binding sites from a pool of degenerate oligonucleotides reveals that CpG-binding protein interacts with a variety of sequences that contains the CpG dinucleotide with a consensus binding site of (A/C)CpG(A/C). Mutation of the CpG motif(s) present within ligand-selected oligonucleotides ablates the interaction with CpG-binding protein, and mutation to thymine of the nucleotides flanking the CpG motifs reduces the affinity of CpG-binding protein. Hence, a CpG motif is necessary and sufficient to comprise a binding site for CpG-binding protein, although the immediate flanking sequence affects binding affinity.
引用
收藏
页码:44669 / 44676
页数:8
相关论文
共 35 条
[1]   Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 [J].
Amir, RE ;
Van den Veyver, IB ;
Wan, M ;
Tran, CQ ;
Francke, U ;
Zoghbi, HY .
NATURE GENETICS, 1999, 23 (02) :185-188
[2]   DNA hypermethylation in tumorigenesis - epigenetics joins genetics [J].
Baylin, SB ;
Herman, JG .
TRENDS IN GENETICS, 2000, 16 (04) :168-174
[3]   CLONING AND SEQUENCING OF A CDNA-ENCODING DNA METHYLTRANSFERASE OF MOUSE CELLS - THE CARBOXYL-TERMINAL DOMAIN OF THE MAMMALIAN ENZYMES IS RELATED TO BACTERIAL RESTRICTION METHYLTRANSFERASES [J].
BESTOR, T ;
LAUDANO, A ;
MATTALIANO, R ;
INGRAM, V .
JOURNAL OF MOLECULAR BIOLOGY, 1988, 203 (04) :971-983
[4]   ACTIVATION OF MAMMALIAN DNA METHYLTRANSFERASE BY CLEAVAGE OF A ZN BINDING REGULATORY DOMAIN [J].
BESTOR, TH .
EMBO JOURNAL, 1992, 11 (07) :2611-2617
[5]   CPG ISLANDS AS GENE MARKERS IN THE VERTEBRATE NUCLEUS [J].
BIRD, AP .
TRENDS IN GENETICS, 1987, 3 (12) :342-347
[6]   SP1 ELEMENTS PROTECT A CPG ISLAND FROM DE-NOVO METHYLATION [J].
BRANDEIS, M ;
FRANK, D ;
KESHET, I ;
SIEGFRIED, Z ;
MENDELSOHN, M ;
NEMES, A ;
TEMPER, V ;
RAZIN, A ;
CEDAR, H .
NATURE, 1994, 371 (6496) :435-438
[7]   A component of the transcriptional repressor MeCP1 shares a motif with DNA methyltransferase and HRX proteins [J].
Cross, SH ;
Meehan, RR ;
Nan, XS ;
Bird, A .
NATURE GENETICS, 1997, 16 (03) :256-259
[8]   MLL2:: A new mammalian member of the trx/MLL family of genes [J].
FitzGerald, KT ;
Diaz, MO .
GENOMICS, 1999, 59 (02) :187-192
[9]   PCCX1, a novel DNA-binding protein with PHD finger and CXXC domain, is regulated by proteolysis [J].
Fujino, T ;
Hasegawa, M ;
Shibata, S ;
Kishimoto, T ;
Imai, S ;
Takano, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 271 (02) :305-310
[10]   Mechanism of transcriptional regulation by methyl-CpG binding protein MBD1 [J].
Fujita, N ;
Shimotake, N ;
Ohki, I ;
Chiba, T ;
Saya, H ;
Shirakawa, M ;
Nakao, M .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (14) :5107-5118